Moreover, these targets were significantly enriched in many pathways related to cancer and signalling pathways, such as the PI3K-Akt signalling pathway, ErbB signalling pathway and FoxO signalling pathway (Figs. 8B, 9). This evidence concerns the gene AKT1 and cancer.